Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation

Type I interferon (IFN-I) has potent anti-tumor effects against urothelial carcinoma (UC) and may be an alternative treatment option for patients who do not respond to Bacillus Calmette-Guerin. However, the mechanisms that mediate the IFN-I-stimulated immune responses against UC have yet to be eluci...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Plote, Devin, Choi, Woonyoung, Mokkapati, Sharada, Sundi, Debasish, Ferguson, James E, Duplisea, Jon, Parker, Nigel R., Yla-Herttuala, Seppo, Committee, SUO CTC Bladder, McConkey, David, Schluns, Kimberly S., Dinney, Colin P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493227/
https://ncbi.nlm.nih.gov/pubmed/31069136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1577125
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak